Thiazolinone quinoline derivatives having no substitution on the quinoline ring active as CDK1 inhibitors which are useful as anti-proliferation agents such as for treating solid tumors.
The present invention refers to thiazolinone quinoline derivatives of the formula (I) having no substitution on the quinoline ring, and being active as CDK1 inhibitors; to processes for the manufacture of said compounds as well as the use of said compounds for the production of medicaments.